A5070813340- Renal cell carcinoma treatment
- Inflammatory Biomarkers in Disease Prognosis
- Pancreatic and Hepatic Oncology Research
- Economic and Financial Impacts of Cancer
- Multiple and Secondary Primary Cancers
- Cancer, Lipids, and Metabolism
- Cancer Immunotherapy and Biomarkers
Hacettepe University
2021
The prognostic values of systemic inflammatory markers, neutrophil to lymphocyte ratio (NLR), and platelet (PLR) on overall survival (OS) metastatic renal cell carcinoma patients (mRCC) treated with tyrosine kinase inhibitors (TKI) remain unclear. Thus, the present study aimed investigate impact these markers OS mRCC patients.A total 150 receiving TKIs were retrospectively analyzed. Progression-free times analyzed Kaplan–Meier method, log‐rank test was used for comparison. Univariable...
OBJECTIVE The albumin to globulin ratio (AGR) has been demonstrated be associated with survival outcomes in various tumor types. However, the prognostic value of AGR patients metastatic renal carcinoma (mRCC) remains unclear. Therefore, this study aimed investigate impact values predicting overall (OS) mRCC treated targeted therapy. MATERIAL AND METHODS A total 163 therapy between 2008 and 2019 were enrolled. was measured as AGR: albumin/(total protein-albumin). Kaplan-Meier method long-rank...